A detailed history of Jupiter Asset Management LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Jupiter Asset Management LTD holds 394,963 shares of VCYT stock, worth $15.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
394,963
Holding current value
$15.5 Million
% of portfolio
0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$23.03 - $34.33 $9.1 Million - $13.6 Million
394,963 New
394,963 $13.6 Million
Q4 2023

Feb 09, 2024

BUY
$19.72 - $28.68 $274,778 - $399,627
13,934 New
13,934 $383,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.82B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.